Safety, tolerability and pharmacokinetics of R1626, a novel nucleoside analog targeting hcv polymerase: Results from a phase I single dose escalation trial in healthy subjects.

被引：0
|
作者：
Robson, R. [1 ]
Berns, H. [1 ]
Brand, M. [1 ]
Feltner, S. [1 ]
Hill, G. [1 ]
Ipe, D. [1 ]
Love, J. [1 ]
Mannino, M. [1 ]
O'Mara, E. [1 ]
Tu, Y. [1 ]
Washington, C. [1 ]
机构：
[1] Roche Pharmaceut, Christchurch Clin Studies Trust, Christchurch, New Zealand
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [1] Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting HCV polymerase in chronic hcv patients
    Roberts, S.
    Cooksley, G.
    Shaw, D.
    Berns, H. K.
    Brandl, M. T.
    Fettner, S. H.
    Hill, G.
    Ipe, D.
    Klumpp, K.
    Mannino, M.
    O'Mara, E.
    Tu, Y.
    Washington, C. B.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S269 - S269
  • [2] Results of a phase 1B, multiple dose study of R1626, a novel nucleoside analog targeting HCV polymerase in chronic HCV genotype 1 patients
    Roberts, Stuart
    Cooksley, Graham
    Dore, Greg
    Robson, Richard
    Shaw, David
    Berns, Heather
    Brandl, Michael
    Fettner, Scoff
    Hill, George
    Ipe, David
    Klumpp, Klaus
    Mannino, Marie
    O'Mara, Edward
    Tu, Yaping
    Washington, Carla
    [J]. HEPATOLOGY, 2006, 44 (04) : 692A - 692A
  • [3] Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial
    Georgoff, Patrick E.
    Nikolian, Vahagn C.
    Bonham, Tess
    Pai, Manjunath P.
    Tafatia, Celia
    Halaweish, Ihab
    To, Kathleen
    Watcharotone, Kuanwong
    Parameswaran, Aishwarya
    Luo, Ruijuan
    Sun, Duxin
    Alam, Hasan B.
    [J]. CLINICAL PHARMACOKINETICS, 2018, 57 (02) : 209 - 219
  • [4] Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial
    Patrick E. Georgoff
    Vahagn C. Nikolian
    Tess Bonham
    Manjunath P. Pai
    Celia Tafatia
    Ihab Halaweish
    Kathleen To
    Kuanwong Watcharotone
    Aishwarya Parameswaran
    Ruijuan Luo
    Duxin Sun
    Hasan B. Alam
    [J]. Clinical Pharmacokinetics, 2018, 57 : 209 - 219
  • [5] A phase I randomized, double-blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects
    Gu, Kenan
    Ruff, Dennis
    Key, Cassandra
    Thompson, Marissa
    Jiang, Shoshanna
    Sandison, Taylor
    Flanagan, Shawn
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (07): : 1592 - 1598
  • [6] A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects
    Liu, Yubin
    Wang, Meixia
    Dong, Xiaona
    He, Jia
    Zhang, Lin
    Zhou, Ying
    Xia, Xia
    Dou, Guifang
    Wu, Chu-tse
    Jin, Jide
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (03):
  • [7] Pharmacokinetics and pharmacodynamics of valopicitabine (NM283), a new nucleoside HCV polymerase inhibitor: Results from a phase I/II dose-escalation trial in patients with HCV-1 infection
    Zhou, XJ
    Afdhal, N
    Godofsky, E
    Dienstag, J
    Rustgi, V
    Schick, L
    McInery, D
    Fielman, BA
    Brown, NA
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 229 - 229
  • [8] Pharmacokinetics and pharmacodynamics of valopicitabine (nm283), a new nucleoside HCV polymerase inhibitor: Results from a phase I/II dose-escalation trial in patients with HCV-1 infection
    Zhou, XJ
    Afdhal, N
    Godofsky, E
    Dienstag, J
    Rustgi, V
    Schick, L
    Duncan, L
    Constance, BF
    Chao, G
    Brown, NA
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A700 - A700
  • [9] Safety, Tolerability and Pharmacokinetics of Bencycloquidium Bromide, a Novel Inhaled Anticholinergic Bronchodilator, in Healthy Subjects: Results from Phase I Studies
    Luo, Zhu
    Hu, Chao
    Pan, Yuanyuan
    Miao, Jia
    Wang, Ying
    Ding, Li
    Liang, Maozhi
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 157
  • [10] Phase I single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of BMS-927711 in healthy subjects
    G Tong
    I Savant
    N Jariwala
    D Burt
    N Zheng
    A Buzescu
    R Bertz
    S Keswani
    R Marcus
    [J]. The Journal of Headache and Pain, 2013, 14
12345